Paracetamol poisoning is among the commonest causes of acute liver failure and of referral to transplant centres worldwide [9, 12]. Acetylcysteine, which replenishes glutathione, is highly effective when it is started early, and is most protective when given within about 8 hours of an acute ingestion; its effect falls as liver injury becomes established [1, 2]. Every step of the assessment is therefore built to avoid two errors: withholding treatment from a patient at risk, and giving an unnecessary infusion to one who is not.
National guidance differs in its detail. This article follows the common ground of the US and Canadian consensus statement [1] and the Australian and New Zealand guideline [2], and notes where UK practice differs. The local protocol and the poisons information centre take precedence.